In the past couple of weeks I’ve had several articles published on Canadian news issues, covering a range of topics. They’re summarised below in small, bitesized chunks for easy digestion (with all the rich food around this time of year, not to mention the woozy post-party heads, it seemed best):
The story’s about a legal battle being fought by a group of business owners who applied to emigrate to Canada through a scheme for people worth $1.6m, with $400,000 to invest locally.
The action was sparked by the would-be investors’ fears that their visa applications could be torn up due to immigration policy changes. This is what happened to 280,000 people who applied through the federal skilled worker scheme.
The story’s been followed up by CBC News today.
I wrote about the new Bank of England governor Mark Carney, and the approach he’s taken to bankers’ bonuses in his role as the Bank of Canada’s governor and chairman of the G20’s Financial Stability Board.
The body that channels most of the $1billion of public funds given to medical researchers has relaxed the rules on how quickly they need to publish their results.
The decision’s being seen by critics as another sign that Canada is less transparent than it should be regarding health research, which many argue is leading to problems such as serious adverse events in clinical trials being glossed over or excluded from published studies.
Trudo Lemmens, chair in health law and policy at the University of Toronto, argues that Canada is behind Europe and the USA regarding transparency in medical research. Interestingly, he suggests that the well publicised problems with the health system south of the border lead to a complacency in Canada about the state of its own healthcare system and the need for tougher regulations.
What’s been your experience of Canadian healthcare?